BamSEC and AlphaSense Join Forces
Learn More

Filana Therapeutics Inc. – Material Contracts

NASDAQ: FLNA    
Share price (4/6/26): $1.68    
Market cap (4/6/26): $81.2 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.11
from 10-K 43 pages Cassava Sciences, Inc. Shares of Common Stock (Par Value $0.001 Per Share) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-10.1
from 8-K 3 pages Amended Non-Employee Director Compensation Program
12/34/56
EX-10.3
from 8-K 10 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.2
from 8-K 10 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 13 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Would Likely Cause Competitive Harm if Publicly Disclosed. Such Portions Are Marked as Indicated With Brackets (“[***]”) Below. Cassava Sciences, Inc. 2020 Cash Incentive Bonus Plan [As Amended by the Board of Directors and Approved by the Delaware Court of Chancery Effective March 6, 2025]
12/34/56
EX-10.24
from 10-K 10 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 38 pages 1. Background
12/34/56
EX-10.1
from 8-K/A 9 pages Executive Employment Agreement
12/34/56
EX-10.1
from 8-K 8 pages Consulting Agreement
12/34/56
EX-10.1
from 8-K 1 page Amendment to Employment Agreement
12/34/56
EX-10.3
from 10-Q 3 pages Non-Employee Director Compensation Program
12/34/56
EX-10.2
from 10-Q 13 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both (I) Not Material and (II) Would Likely Cause Competitive Harm if Publicly Disclosed. Such Portions Are Marked as Indicated With Brackets (“[***]”) Below. Cassava Sciences, Inc. 2020 Cash Incentive Bonus Plan [As Amended by the Board of Directors Effective March 16, 2023]
12/34/56
EX-10.1
from 8-K 35 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 5 pages Personal and Confidential 
12/34/56
EX-10.1
from 10-Q 1 page  Amendment No. 1 to the Cassava Sciences, Inc. 2018 Omnibus Incentive Plan
12/34/56
EX-10.1
from 10-K 15 pages Indemnification Agreement
12/34/56
EX-10.4
from 10-Q 81 pages  Agreement of Sale and Purchase  Between  Dwf IV Lakewood, LP, a Delaware Limited Partnership  “Seller”  and  Cassava Sciences, Inc., a Delaware Corporation “Buyer”  With Escrow Instructions for  Heritage Title Company  “Escrow Agent” 
12/34/56
EX-10.3
from 10-Q 44 pages  Master Services Agreement
12/34/56
EX-10.1
from 8-K 18 pages  Master Services Agreement
12/34/56
EX-10.1
from 8-K 34 pages Securities Purchase Agreement
12/34/56